Convegni | ARCO – ONLUS | Attività Ricerca Clinica Oncologica

CONGRESSO ASCO 2015

Posted on 3 giugno 2015

Prognostic value of HPV detection with three primer sets in 255 Head-Neck cancers. Con i seguenti autori: Cristiana Lo Nigro, Daniela Vivenza, Martino Monteverde,Mirella Fortunato, Nerina Denaro, Laura Lattanzio, Federica Tonissi, Valentina Astesana, Elvio Russi e Marco Merlano. Afferenti al dipartimento di Oncologia (Laboratorio di Genetica Oncologica ed Oncologia Traslazionale o Oncologia Medica), Dipartimento di […]

Paclitaxel or nab-paclitaxel with bevacizumab: in vitro study

Posted on 17 dicembre 2014

Lo Nigro C, Garrone O, Tonissi F, Lattanzio L, Ghiglia A, Vivenza D, Monteverde M, Merlano M: “Paclitaxel or nab-paclitaxel with bevacizumab: in vitro study”, XVI Congresso Nazionale AIOM, Roma, 24-26 ottobre 2014.

Detection and prognostic role of HPV in head and neck carcinoma

Posted on

Lo Nigro C, Vivenza D, Monteverde M,, Fortunato M, Denaro N, Lattanzio L, Tonissi F, Ghiglia A, Russi E, Merlano M: “Detection and prognostic role of HPV in head and neck carcinoma”, 19th World Congress on Advances in Oncology and 17th International Symposium on Molecular Medicine , 9-11 ottobre 2014, Atene, Grecia.

Paclitaxel or nab-paclitaxel with bevacizumab: in vitro study

Posted on

Lo Nigro C, Garrone O, Tonissi F, Lattanzio L, Ghiglia A, Vivenza D, Monteverde M, Merlano M: “Paclitaxel or nab-paclitaxel with bevacizumab: in vitro study”, 38th ESMO Congress, Madrid, Spain, 26-30 Settembre 2014.

Paclitaxel or nab-paclitaxel with bevacizumab: in vitro study

Posted on

Lo Nigro C, Garrone O, Tonissi F, Lattanzio L, Ghiglia A, Vivenza D, Monteverde M, Merlano M: “Paclitaxel or nab-paclitaxel with bevacizumab: in vitro study”, XVII Congresso Nazionale SIC, Ferrara, 11-13 settembre 2014.

Paclitaxel or nab-paclitaxel with bevacizumab: in vitro study”, 3rd International Conference

Posted on

Lo Nigro C, Garrone O, Tonissi F, Lattanzio L, Ghiglia A, Vivenza D, Monteverde M, Merlano M: “Paclitaxel or nab-paclitaxel with bevacizumab: in vitro study”, 3rd International Conference “Translational Research in Oncology, Forlì, 6-9 maggio 2014.

Combination of PI3KCA targeting with irradiation: a preclinical study on head and neck cancer cell lines

Posted on

Lo Nigro C, Lattanzio L, Tonissi F, Ghiglia A, Gianello L, Russi E, Milano G, Merlano M: “Combination of PI3KCA targeting with irradiation: a preclinical study on head and neck cancer cell lines”, 3rd International Conference “Translational Research in Oncology, Forlì, 6-9 maggio 2014.

Combination of PI3KCA targeting with irradiation: a preclinical study on head and neck cancer cell lines

Posted on

Lattanzio L, Tonissi F, Monteverde M, Gianello L, Russi E, Merlano M, Lo Nigro C, Milano G: “Combination of PI3KCA targeting with irradiation: a preclinical study on head and neck cancer cell lines”, 105th AACR Annual Meeting, San Diego, CA (USA), 5-9 aprile 2014.

HPV16 detection by PCR in serum of HNSCC patients and comparison with primary tumour tissue

Posted on

Vivenza D, Monteverde M, Denaro N, Fortunato M, Comino A, Merlano MC, Lo Nigro C: “HPV16 detection by PCR in serum of HNSCC patients and comparison with primary tumour tissue”, 105th AACR Annual Meeting, San Diego, CA (USA), 5-9 aprile 2014.

HPV16 detection by PCR in serum of HNSCC patients and comparison with primary tumour tissue

Posted on

Vivenza D, Monteverde M, Denaro N, Fortunato M, Comino A, Merlano MC, Lo Nigro C: “HPV16 detection by PCR in serum of HNSCC patients and comparison with primary tumour tissue”, European Congress Head and Neck Oncology (ECHNO) 2014, Liverpool (UK), 24-26 aprile 2014.